| 发明名称 |
Crystalline drug form |
| 摘要 |
The present invention relates to a crystalline form of 6-[(2,2-diphenylethyl)amino]-9-(N-ethyl-beta-D-ribofuranosyluronamide)-N-(2-{N'-[1-(2-pyridyl)-4-piperidyl]ureido}ethyl)-9H-purine-2-carboxamide and to a process for the preparation of, compositions containing and the uses of such a crystalline form.
|
| 申请公布号 |
US2003158145(A1) |
申请公布日期 |
2003.08.21 |
| 申请号 |
US20020308805 |
申请日期 |
2002.12.03 |
| 申请人 |
SILK TERENCE VERNON;SMITH JULIAN DUNCAN |
发明人 |
SILK TERENCE VERNON;SMITH JULIAN DUNCAN |
| 分类号 |
A61K31/46;A61K31/4745;A61K31/70;A61K31/7076;A61K47/48;C07H19/16;(IPC1-7):C07H19/16;A61K31/707 |
主分类号 |
A61K31/46 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
